← Leaderboards
Tian Wang
University Of Texas Med Br Galveston
$11,943,039
Attributed
$13,479,736
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,479,736 · 11
By mechanism
R01$11,146,681 · 5
R21$1,736,326 · 3
T35$298,901 · 1
R03$297,828 · 2
Top collaborators
- Ping Wu4 shared
- Wenbo Zhang3 shared
- Zhongde Wang2 shared
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Ping Wu$3,932,683
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionVaccinesImmuneVirus DiseasesCellsDisease OutbreaksImmune ResponseResponsePathogenImmunityVirusBrainProductionMediatingIn VivoFlavivirusReportingTransmission ProcessWest Nile VirusCytokineViralInflammationInflammatoryAffect
Grant awards (41)
Porous silicon microparticle-based subunit vaccines for SARS-CoV-2$681,312
R01 · FY2025 · AI · contact PI
Role of microglia in neural infection$464,451
R01 · FY2025 · NS
Novel Hamster Models of Chikungunya Viral Arthritis$196,407
R21 · FY2025 · AI · contact PI
Infectious Diseases and Inflammatory Disorders Training Program$58,548
T35 · FY2025 · AI · contact PI
Porous silicon microparticle-based subunit vaccines for SARS-CoV-2$671,187
R01 · FY2024 · AI · contact PI
Role of microglia in neural infection$500,574
R01 · FY2024 · NS
Novel Hamster Models of Chikungunya Viral Arthritis$247,852
R21 · FY2024 · AI · contact PI
Infectious Diseases and Inflammatory Disorders Training Program$69,495
T35 · FY2024 · AI · contact PI
Porous silicon microparticle-based subunit vaccines for SARS-CoV-2$613,059
R01 · FY2023 · AI · contact PI
Role of microglia in neural infection$516,055
R01 · FY2023 · NS
Infectious Diseases and Inflammatory Disorders Training Program$47,762
T35 · FY2023 · AI · contact PI
Role of microglia in neural infection$516,055
R01 · FY2022 · NS
Infectious Diseases and Inflammatory Disorders Training Program$62,273
T35 · FY2022 · AI · contact PI
Revolutionary Eilat-based Chikungunya Vaccine Vector$825,842
R01 · FY2021 · AI · contact PI
Infectious Diseases and Inflammatory Disorders Training Program$60,823
T35 · FY2021 · AI · contact PI
Revolutionary Eilat-based Chikungunya Vaccine Vector$767,732
R01 · FY2020 · AI · contact PI
Administrative Supplement: Investigation of Zika Virus-Induced Retinopathy using Developing Mouse Retina$197,500
R21 · FY2020 · EY
Pellino-1, a novel target for treatment of congenital Zika syndrome$197,500
R21 · FY2020 · AI · contact PI
Investigation of Zika virus-induced retinopathy using developing mouse retina$197,500
R21 · FY2020 · EY
Role of Pellino-1 in COVID-19 diseases$184,865
R21 · FY2020 · AI · contact PI
Pellino-1, a novel target for treatment of congenital Zika syndrome$40,702
R21 · FY2020 · AI · contact PI
Revolutionary Eilat-based Chikungunya Vaccine Vector$772,684
R01 · FY2019 · AI · contact PI
Pellino-1, a novel target for treatment of congenital Zika syndrome$237,000
R21 · FY2019 · AI · contact PI
Investigation of Zika virus-induced retinopathy using developing mouse retina$237,000
R21 · FY2019 · EY
Revolutionary Eilat-based Chikungunya Vaccine Vector$302,302
R01 · FY2018 · AI · contact PI
Revolutionary Eilat-based Chikungunya Vaccine Vector$855,817
R01 · FY2017 · AI · contact PI
Rational Development of Candidate Attenuated Flavivirus Vaccines$617,756
R01 · FY2016 · AI · contact PI
Rational Development of Candidate Attenuated Flavivirus Vaccines$387,500
R01 · FY2015 · AI · contact PI
Rational Development of Candidate Attenuated Flavivirus Vaccines$387,188
R01 · FY2014 · AI · contact PI
Rational Development of Candidate Attenuated Flavivirus Vaccines$363,075
R01 · FY2013 · AI · contact PI
Gammadelta T cell Regulation of Adaptive Immunity in West Nile Virus Infection$367,864
R01 · FY2012 · AI · contact PI
Role of Gamma/Delta T Cells in West Nile Virus Pathogenesis$76,500
R03 · FY2012 · AI · contact PI
Gammadelta T cell Regulation of Adaptive Immunity in West Nile Virus Infection$366,803
R01 · FY2011 · AI · contact PI
Role of Gamma/Delta T Cells in West Nile Virus Pathogenesis$76,500
R03 · FY2011 · AI · contact PI
Gammadelta T cell Regulation of Adaptive Immunity in West Nile Virus Infection$370,508
R01 · FY2010 · AI · contact PI
Gammadelta T cell Regulation of Adaptive Immunity in West Nile Virus Infection$374,250
R01 · FY2009 · AI · contact PI
Gammadelta T cell Regulation of Adaptive Immunity in West Nile Virus Infection$56,162
R01 · FY2009 · AI · contact PI
Gammadelta T cell Regulation of Adaptive Immunity in West Nile Virus Infection$217,505
R01 · FY2008 · AI · contact PI
Gammadelta T cell Regulation of Adaptive Immunity in West Nile Virus Infection$151,000
R01 · FY2008 · AI · contact PI
MyD88-mediated innate immunity against West Nile virus$71,369
R03 · FY2007 · AI · contact PI
MyD88-mediated innate immunity against West Nile virus$73,459
R03 · FY2006 · AI · contact PI